Congenital myasthenic syndromes and myasthenia

Botulinum toxin type A (BTA) is widely used for both medical treatment and cosmetic purposes. Botulinum toxin type A is a potent neurotoxin and produced by the anaerobic bacterium Clostridium botulinum: It paralyzes the injected muscle by inhibiting acetylcholine release from synapses of neuromuscular junctions and consequently, a dose dependent, reversible denervation develops in muscles. With increasing numbers of people receiving cosmetic botulinum toxin, we should consider the side effects of botulinum toxin type A carefully.
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research